Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 · kind E1 · reissue
2Cited by
25References
79Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 24, 2020 |
| Grant date | Mar 7, 2023 |
| Priority date | — |
| Expiry date | Dec 24, 2040 |
Classification
- Technology area (CPC —)General
Abstract
The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) and methods of using a PTHrP and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.